Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction
1999 Standout
Incidence of and Risk Factors for Skin Cancer After Heart Transplant
2009
Awareness of skin cancer by kidney transplant patients
1999
From Pharmacokinetics to Pharmacogenomics: A New Approach to Tailor Immunosuppressive Therapy
2004
Endovascular Stent–Graft Placement for the Treatment of Acute Aortic Dissection
1999 Standout
Liver and kidney preservation by perfusion
2002
Organ Donors with Malignant Gliomas: An Update
2003
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study
2000 Standout
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease
1994
Axillary artery cannulation: routine use in ascending aorta and aortic arch replacement
2004
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Systemic sclerosis
2017 Standout
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Plant-based foods and prevention of cardiovascular disease: an overview
2003 Standout
Skin Cancers after Organ Transplantation
2003 Standout
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens
1999
Skeletal remodeling in health and disease
2007 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin E
1995
Aspergillus Pericarditis with Tamponade: Report of a Successfully Treated Case and Review
1998
Cardiovascular Toxicities of Immunosuppressive Agents
2002
Sudden, unexpected death in cardiac transplant recipients: an autopsy study
2004
INTERFERON-?? TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RECIPIENTS OF SOLID ORGAN TRANSPLANTS1
1998
Inhibition of nuclear factor-κB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy
2003 StandoutNobel
Growth rate of left atrial myxoma
1989
Combination Effect of Mycophenolate Mofetil with Mizoribine on Cell Proliferation Assays and in a Mouse Heart Transplantation Model
2006
Graft-versus-host disease
2009 Standout
Epidemiology of actinic keratoses and squamous cell carcinoma
2000
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Platelets in inflammation and atherogenesis
2005 Standout
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis
2006
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation
2004
Elements of Mediterranean diet improve oxidative status in blood of kidney graft recipients
2005
Machine Perfusion or Cold Storage in Deceased-Donor Kidney Transplantation
2008 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Cardiac Myxomas
1995 Standout
Costimulation Blockade with Belatacept in Renal Transplantation
2005 Standout
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Osteoporosis after solid organ and bone marrow transplantation
2003
Infection in Solid-Organ Transplant Recipients
2007 Standout
Immunosuppression for heart transplantation: where are we now?
2006
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Reversal of chronic cyclosporine nephrotoxicity after heart transplantation—potential role of mycophenolate mofetil
2002
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Immunosuppressive strategies in transplantation
1999
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ-secreting, T lymphocytes
1999 StandoutNobel
Adherence to a Mediterranean Diet and Survival in a Greek Population
2003 Standout
High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometry
1999
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
2008 Standout
Extracellular BCL2 Proteins Are Danger-Associated Molecular Patterns That Reduce Tissue Damage in Murine Models of Ischemia-Reperfusion Injury
2010
Humoral Theory of Transplantation
2003
Cutaneous Squamous-Cell Carcinoma
2001 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Epstein–Barr Virus Infection
2000 Standout
Efficacy of Pamidronate for Osteoporosis in Patients with Cystic Fibrosis following Lung Transplantation
2000
Role of the Glutathione Metabolic Pathway in Lung Cancer Treatment and Prognosis: A Review
2006
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
Disorders Associated With Acute Rapid and Severe Bone Loss
2003
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
PREDNISONE WITHDRAWAL IN KIDNEY TRANSPLANT RECIPIENTS ON CYCLOSPORINE AND MYCOPHENOLATE MOFETIL-A PROSPECTIVE RANDOMIZED STUDY1,2
1999
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
2008 Standout
Natural Innate and Adaptive Immunity to Cancer
2011 Standout
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Changes in Surface Expression of Platelet Membrane Glycoproteins and Progression of Heart Transplant Vasculopathy
2000
Recurring cardiac myxoma.
1985
Effects of a Mediterranean-Style Diet on Cardiovascular Risk Factors
2006 Standout
Evolution of Liver Transplantation
1982
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Cardiac Allograft Vasculopathy
2008
Metabolic reprogramming and cancer progression
2020 StandoutScience
The significance of multiple, recurrent, and “complex” cardiac myxomas
1986
The malignant potentiality of left atrial myxoma
1974
Regenerative Potential of Cardiosphere-Derived Cells Expanded From Percutaneous Endomyocardial Biopsy Specimens
2007
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY
1984 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative
2004
Influenza vaccine antibody responses in lung transplant recipients
2004
Effect of Calcitriol on Bone Loss After Cardiac or Lung Transplantation
2000
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
2002 Standout
Aggressive cutaneous malignancies following cardiothoracic transplantation
1999
A balloon-expandable intravascular stent for obliterating experimental aortic dissection
1990
Transmission of glioblastoma multiforme following bilateral lungtransplantation from an affected donor: Case study and review of theliterature
2004
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Recommendations for the Outpatient Surveillance of Renal Transplant Recipients
2000
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Influenza Vaccine Antibody Responses in Lung Transplant Recipients
2004
Works of G Dureau being referenced
Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation
1995
Introduction of mycophenolate mofetil and cyclosporine withdrawal in heart transplant patients with progressive deteriorating renal function
2000
Three-Year Results of a Randomized, Double-Blind, Controlled Trial of Mycophenolate Mofetil Versus Azathioprine in Cardiac Transplant Recipients
2005
Bone loss after cardiac transplantation: Effects of calcium, calcidiol and monofluorophosphate
1993
Effects of a French Mediterranean diet on heart transplant recipients with hypercholesterolemia
1994
Accelerated coronary artery disease after heart transplantation: the role of enhanced platelet aggregation and thrombosis
1993
Increased lipid peroxidation in cyclosporin-treated heart transplant recipients
1991
Post‐transplant lymphoproliferative disorders with genetic abnormalities commonly found in malignant tumours
1995
A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1
1998
Mycophenolate mofetil decreases antibody production after cardiac transplantation
2002
HIGH PREVALENCE OF THROMBOEMBOLIC COMPLICATIONS IN HEART TRANSPLANT RECIPIENTS
1996
Pharmacokinetics of cyclosporine in hyperlipidaemic long-term survivors of heart transplantation
1992
Quantitative Reduction of MTT by Hearts Biopsies In Vitro is an Index of Viability
1993
THIOPURINE S-METHYLTRANSFERASE GENE POLYMORPHISM IS PREDICTIVE OF AZATHIOPRINE-INDUCED MYELOSUPPRESSION IN HEART TRANSPLANT RECIPIENTS
2000
[Orthotopic transplantation of the liver in dogs].
1965
Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients.
1994
THE BENEFICIAL EFFECT OF DIETARY ANTIOXIDANT SUPPLEMENTATION ON PLATELET AGGREGATION AND CYCLOSPORINE TREATMENT IN HEART TRANSPLANT RECIPIENTS
1994
Post-transplant B-cell lymphomas--correlation of late stage B-cell differentiation and progression of disease; treatment with chimeric monoclonal antibody.
1995
Aggressive squamous cell carcinomas in organ transplant recipients.
1995
Transmission of medulloblastoma from cadaver donor to three organ transplant recipients.
1987
[Type I, complete, acute aortic dissection. Value of arterial perfusion by the axillary route (author's transl)].
1976
Three-Year Allograft Vasculopathy Results of the Multicenter Heart Transplant Mycophenolate Mofetil Randomized Trial
1999
Increased platelet aggregation after heart transplantation: influence of aspirin.
1991
New surgical technique for the operative management of acute dissections of the ascending aorta
1978
Homotransplantation of the canine liver after hypothermic perfusion of long duration.
1967
[A series of 10 operated cases of intracardiac myxoma].
1973
[Pericardium and heart transplantation].
1994
[Orthotopic transplantation of the liver in dogs. II. Immunosuppressive treatment (Imuran, Actinomycin C)].
1965
EVALUATION OF TICLOPIDINE, A NOVEL INHIBITOR OF PLATELET AGGREGATION, IN HEART TRANSPLANT RECIPIENTS
1993